Tango Therapeutics, Inc.TNGXNASDAQ
LOADING
|||
Cash Flow Under Pressure
Trending lower, below historical average, strong compound growth.
Left:
||||
Operating cash flow minus capital expenditures
Latest
$-132.25M
↓ 105% below average
Average (5y)
$-64.59M
Historical baseline
Range
High:$68.97M
Low:$-132.25M
CAGR
+37.8%
Consistent expansion
| Period | Value | Change |
|---|---|---|
| 2024 | $-132.25M | -10.7% |
| 2023 | $-119.51M | -2.3% |
| 2022 | $-116.77M | -90.3% |
| 2021 | $-61.36M | -189.0% |
| 2020 | $68.97M | +359.1% |
| 2019 | $-26.62M | - |